A novel hypocrellin B derivative designed and synthesized by taking consideration to both drug delivery and biological photodynamic activity

Journal of Photochemistry and Photobiology B: Biology

Volumn 94, Issue 3, 2009, Pages 171-178

  Liu, Xin ^a   Xie, Jie ^a   Zhang, Luyong ^b   Chen, Hongxia ^b   Gu, Ying ^b   Zhao, Jingquan ^a  

^a PEKING UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

EPR spectra; Hypocrellins; Photodynamic therapy (PDT); Photosensitization activity; Singlet oxygen

Indexed keywords

17 3 AMINO 1 PROPANE SULFONIC ACID HYPOCRELLIN B SCHIFF BASE; ANION; FREE RADICAL; HYPOCRELLIN B; OXYGEN; PHOSPHATE BUFFERED SALINE; PHOTOSENSITIZING AGENT; SEMIQUINONE; SOLVENT; SUPEROXIDE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CANCER CELL CULTURE; CIRCULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG SOLUBILITY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; PARTITION COEFFICIENT; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PHOTOTHERAPY; PRIORITY JOURNAL; QUANTUM YIELD; RED LIGHT; SOLID TUMOR; TARGET ORGAN;

CELL LINE; DRUG DESIGN; HUMANS; PERYLENE; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; QUINONES; SCHIFF BASES; SOLUBILITY;

EID: 60549110212     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jphotobiol.2008.11.008     Document Type: Article

References (60)

1. Henderson B.W., and Dougherty T.J. How does photodynamic therapy work. Photochem. Photobiol. 55 (1992) 145-157
2. Dougherty T.J., and Marcus S.L. Photodynamic therapy. Eur. J. Cancer 28A (1992) 1734-1742
3. Morris R.L., Azizuddin K., Lam M., Berlin J., Nieminen A.L., Kenney M.E., Samia A.C.S., Burda C., and Oleinick N.L. Fluorescence resonance energy transfer reveals a binding site of a photosensitizer for photodynamic therapy. Cancer Res. 63 (2003) 5194-5197
4. Zhang L., Gu Y., Liu F.G., Liu Y.Y., Zhao X.M., and Zeng J. Effect of photodynamic therapy on rat mesenteric microcircuIation. Chinese J. Laser Med. Surg. 12 (2003) 69-75
5. Miller J.W., Schmidt-Erfurth U., Sickenberg M., Pournaras C.J., Laqua H., Barbazetto I., Zografos L., Piguet B., Donati G., Lane A.M., Birngruber R., van den Berg H., Strong A., Manjuris U., Gray T., Fsadni M., Bressler N.M., and Gragoudas E.S. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch. Ophthalmol. 117 (1999) 1161-1173
6. Wu L., and Murphy R.P. Photodynamic therapy: a new approach to the treatment of choroidal neovascularization secondary to age-related macular degeneration. Curr. Opin. Ophthalmol. 10 (1999) 217-220
7. Brown S.B., Brown E.A., and Walker I. The present and future role of photodynamic therapy in cancer treatment. Lancet Oncol. 5 (2004) 497-508
8. Diwu Z.J., and Lown J.W. Photosensitization by anticancer agents. 12. perylene quinonoid pigments, a novel type of singlet oxygen sensitizer. J. Photochem. Photobiol. A 64 (1992) 273-287
9. Zang L.Y., Misra B.R., and Misra H.P. Generation of free radicals during photosensitization of hypocrellin A and their effects on cardiac membranes. Photochem. Photobiol. 56 (1992) 453-462
10. Diwu Z.J., and Lown J.W. Photosensitization with anticancer agents. 15. perylenequinonoid pigments as potential photodynamic therapeutic agents - formation of semiquinone radicals and reactive oxygen species on illumination. J. Photochem. Photobiol. B 18 (1993) 131-143
11. Diwu Z.J., Zhang C.L., and Lown J.W. Photosensitization with anticancer agents .18. perylenequinonoid pigments as potential photodynamic therapeutic agents - preparation and photodynamic properties of amino-substituted hypocrellin derivatives. Anti-Cancer Drug Des. 8 (1993) 129-143
12. Miller G.G., Brown K., Ballangrud A.M., Barajas O., Xiao Z., Tulip J., Lown J.W., Leithoff J.M., AllalunisTurner M.J., Mehta R.D., and Moore R.B. Preclinical assessment of hypocrellin B and hypocrellin B derivatives as sensitizers for photodynamic therapy of cancer: progress update. Photochem. Photobiol. 65 (1997) 714-722
13. Jiang L.J., and He Y.Y. Photophysics, photochemistry and photobiology of hypocrellin photosensitizers. Chinese Sci. Bull. 46 (2001) 6-16
14. Tang Y.J., Liu H.Y., An J.Y., and Han R. Synthesis, characterization and photodynamic activity of amino-substituted hypocrellin derivatives. Photochem. Photobiol. 74 (2001) 201-205
15. Xu S.J., Zhang X.X., Chen S., Zhang M.H., Shen T., and Wang Z.P. Novel phototherapeutic agents: investigation and progress of hypocrellin derivatives. Chinese Sci. Bull. 48 (2003) 1775-1785
16. Diwu Z.J.J., Haugland R.P., Liu J.X., Lown J.W., Miller G.G., Moore R.B., Brown K., Tulip J., and McPhee M.S. Photosensitization by anticancer agents .21. New perylene- and aminonaphthoquinones. Free Rad Biol. Med. 20 (1996) 589-593
17. Weng M., Zhang M.H., Ma L., Shen T., and Jiang L.J. New long-wavelength perylenequinones. The reaction between hypocrellin B and mercapto compounds. Dyes Pigments 35 (1997) 297-310
18. Weng M., Zhang M.H., and Shen T. Mercapto-substituted perylenequinonoid pigments. A new type of singlet oxygen sensitizer. Dyes Pigments 36 (1998) 93-102
19. Zhang W.G., Weng M., Pang S.Z., Zhang M.H., Yang H.Y., Zhao H.X., and Zhang Z.Y. A novel photosensitizer, 2-butylamino-2-demethoxy-hypocrellin A (2-BA-2-DMHA) - 1. Synthesis of 2-BA-2-DMHA and its phototoxicity to MGC803 cells. J. Photochem. Photobiol. B 44 (1998) 21-28
20. He Y.Y., An J.Y., and Jiang L.J. Synthesis of a new water-soluble phototherapeutic sensitizer from hypocrellin B with enhanced red absorption. Dyes Pigments 41 (1999) 93-100
21. Wu T., Xu S.J., Shen J.Q., Song A.M., Chen S., Zhang M.H., and Shen T. New potential photodynamic therapeutic anti-cancer agents: synthesis and characterization of demethoxy amino-substituted hypocrellins. Anti-Cancer Drug Des. 15 (2000) 287-293
22. Xu S.J., Chen S., Zhang M.H., and Shen T. Hypocrellin derivative with improvements of red absorption and active oxygen species generation. Bioorg. Med. Chem. Lett. 14 (2004) 1499-1501
23. Zhao Y.W., Xie J., Ma J.S., and Zhao J.Q. A novel amphiphilic 2-taurine substituted hypocrellin B (THB) and its photodynamic activity. New J. Chem. 28 (2004) 484-489
24. Hu Y.Z., An J.Y., Jiang L.J., and Chiang L.C. Studies of the sulfonation of hypocrellin-a and the photodynamic actions of the product. J. Photochem. Photobiol. B 17 (1993) 195-201
25. Ou Z.Z., Chen J.R., Wang X.S., Zhang B.W., and Cao Y. Synthesis and photodynamic therapy properties of a water-soluble hypocrellin modified by cyclodextrin. Chem. Lett. (2001) 838-839
26. He Y.Y., An J.Y., and Jiang L.J. Photodynamic action of a water-soluble hypocrellin derivative with enhanced absorptivity in the phototherapeutic window - I: ESR and UV-Vis studies on the photogeneration of the semiquinone anion radical and hydroquinone. J. Photochem. Photobiol. A 115 (1998) 213-221
27. He Y.Y., An J.Y., and Jiang L.J. Glycoconjugated hypocrellin: synthesis of [(beta-d-glucosyl)ethylthiyl] hypocrellins and photosensitized generation of singlet oxygen. Biochim. Biophys. Acta 1472 (1999) 232-239
28. Ou Z.Z., Chen J.R., Wang X.S., Zhang B.W., and Cao Y. Synthesis of a water-soluble cyclodextrin modified hypocrellin and ESR study of its photodynamic therapy properties. New J. Chem. 26 (2002) 1130-1136
29. Song Y.Z., An J.Y., and Jiang L.J. ESR studies of the photodynamic properties of a long-wavelength and water-soluble hypocrellin B derivative: photogeneration of semiquinone radical anion and activated oxygen. J. Photochem. Photobiol. A 123 (1999) 39-46
30. He Y.Y., Liu H.Y., An J.Y., Han R., and Jiang L.J. Photodynamic action of hypocrellin dyes: structure-activity relationships. Dyes Pigments 44 (1999) 63-67
31. Y.W. Zhao, Study on the clinical application of hypocrellin photodynamic drugs-molecular design, synthesis and photodynamic activities aiming at the peculiarities of different diseases, Institute of Chemistry, Chinese Academy of Science, Beijing, 2004, pp. 87-90.
32. Xu S.J., Chen S., Zhang M.H., and Shen T. Synthesis, characterization and photodynamic activity of phenmethylamino-demethoxy-hypocrellin B. J. Photochem. Photobiol. B 72 (2003) 61-67
33. Qiao R., Zeng Z.H., Xia S.Q., Zhou J.H., Liu Y.Y., Chen J.R., Wang X.S., and Zhang B.W. Using electrostatic interactions to increase the photodamaging ability of hypocrellin B: synthesis and study of 2-(dimethylamino)ethanethiol-modied HB. New J. Chem. 31 (2007) 196-198
34. Li L., Chen Y.W., Shen J.Q., Zhang M.H., and Shen T. New long-wavelength perylenequinones: synthesis and phototoxicity of hypocrellin B derivatives. Biochim. Biophys. Acta 1523 (2000) 6-12
35. Zhao Y.W., and Zhao J.Q. Preparation of a novel hypocrellin derivative and its photochemical, photophysical properties. Dyes Pigments 63 (2004) 175-179
36. Xie J., Ma J.H., and Zhao J.Q. Prediction on amphiphilicity of hypocrellin derivatives. Sci. China Ser. B 45 (2002) 251-256
37. Zhao K.H., and Jiang L.J. Conversion of hypocrellin A in alkaline and neutral media. Youji Huaxue 9 (1989) 252-254
38. Lee H.Y., Zhou Z.X., Chen S., Zhang M.H., and Shen T. New long-wavelength ethanolamino-substituted hypocrellin: photodynamic activity and toxicity to MGC803 cancer cell. Dyes Pigments 68 (2006) 1-10
39. Fisher A.M., Danenberg K., Banerjee D., Bertino J.R., Danenberg P., and Gomer C.J. Increased photosensitivity in HL60 cells expressing wild-type p53. Photochem. Photobiol. 66 (1997) 265-270
40. Leo A., Hansch C., and Elkins D. Partition coefficients and their uses. Chem. Rev. 71 (1971) 525-616
41. Liu H.L., Liu F.G., Gu Y., Ma J.H., Zhao J.Q., Zeng J., and Li X.S. An experimental study of photodynamic effect of hypocrelline B liposome on Leghorn Cock Comb. Chinese J. Laser Med. Surg. 14 (2005) 1-5
42. {radical dot} -) generated during photosensitization of hypocrellin-B. Free Radical Biol. Med. 14 (1993) 1-9
43. Hu Y.Z., An J.Y., Jiang L.J., and Chen D.W. Spectroscopic study on the photoreduction of hypocrellin-a - generation of semiquinone radical-anion and hydroquinone. J. Photochem. Photobiol. A 89 (1995) 45-51
44. Zeng Z.H., Qiao R., Zhou J.H., Xia S.Q., Zhang Y., Liu Y.Y., Chen J.R., Wang X.S., and Zhang B.W. Photodynamic properties of dipeptide-modified hypocrellin B derivatives: the role of tyrosine and tryptophan groups. J. Phy. Chem. B 111 (2007) 3742-3749
45. Xu S.J., Chen S., Zhang M.H., Shen T., Zhao Y.P., Liu Z.W., and Wu Y.D. Butylamino-demethoxy-hypocrellins and photodynamic therapy decreases human cancer in vitro and in vivo. Biochim. Biophys. Acta 1537 (2001) 222-232
46. Harbour J.R., and Hair M.L. Detection of superoxide ions in nonaqueous media. Generation by photolysis of pigment dispersions. J. Phys. Chem. 82 (1978) 1397-1399
47. McCord J.M., and Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244 (1969) 6049-6055
48. Lang K., Wagnerova D.M., Stopka P., and Damerau W. Reduction of dioxygen to superoxide photosensitized by anthraquinone-2-sulfonate. J. Photochem. Photobiol. A 67 (1992) 187-195
49. Zhao B.Z., Xie H., and Zhao J.Q. Binding of hypocrellin B to human serum albumin and photo-induced interactions. Biochim. Biophys. Acta 1722 (2005) 124-130
50. Lion Y., Delmelle M., and van de Vorst A. New method of detecting singlet oxygen production. Nature 263 (1976) 442-443
51. {radical dot} OH) during the photosensitization of a water-soluble perylenequinone derivative. J. Photochem. Photobiol. B 33 (1996) 51-59
52. Detty M.R., Gibson S.L., and Wagner S.J. Current clinical and preclinical photosensitizers for use in photodynamic therapy. J. Med. Chem. 47 (2004) 3897-3915
53. Ochsner M. Photophysical and photobiological processes in the photodynamic therapy of tumours. J. Photochem. Photobiol. B 39 (1997) 1-18
54. Meerovich I.G., Jerdeva V., Derkacheva V.M., Meerovich G.A., Lukyanets E.A., Kogan E.A., and Savitsky A.P. Photodynamic activity of dibiotinylated aluminum sulfophthalocyanine in vitro and in vivo. J. Photochem. Photobiol. B 80 (2005) 57-64
55. Liu C.D., Kwan D., Saxton R.E., and McFadden D.W. Hypericin and photodynamic therapy decreases human pancreatic cancer in vitro and in vivo. J. Surg. Res. 93 (2000) 137-143
56. Adams K., Rainbow A.J., Wilson B.C., and Singh G. In vivo resistance to photofrin-mediated photodynamic therapy in radiation-induced fibrosarcoma cells resistant to in vitro Photofrin-mediated photodynamic therapy. J. Photochem. Photobiol. B 49 (1999) 136-141
57. Ruck A., Beck G., Bachor R., Akgun N., Gschwend M.H., and Steiner R. Dynamic fluorescence changes during photodynamic therapy in vivo and in vitro of hydrophilic A1(III) phthalocyanine tetrasulphonate and lipophilic Zn(II) phthalocyanine administered in liposomes. J. Photochem. Photobiol. B 36 (1996) 127-133
58. Boehncke W.H., Ruck A., Naumann J., Sterry W., and Kaufmann R. Comparison of sensitivity towards photodynamic therapy of cutaneous resident and infiltrating cell types in vitro. Laser Surg. Med. 19 (1996) 451-457
59. Strauss W.S., Sailer R., Schneckenburger H., Akgun N., Gottfried V., Chetwer L., and Kimel S. Photodynamic efficacy of naturally occurring porphyrins in endothelial cells in vitro and microvasculature in vivo. J. Photochem. Photobiol. B 39 (1997) 176-184
60. Svaasand L.O., and Ellingsen R. Optical penetration in human intracranial tumors. Photochem. Photobiol. 41 (1985) 73-76